[TEVA] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -36.70%
YoY- 165.71%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 4,452,000 3,978,000 3,870,000 4,357,000 4,468,000 4,264,000 4,337,000 1.75%
PBT 137,000 -4,459,000 -51,000 -33,000 -38,000 -292,000 -850,000 -
Tax -21,000 16,000 -104,000 -59,000 -119,000 11,000 -179,000 -75.87%
NP 150,000 -4,349,000 140,000 69,000 109,000 -314,000 -689,000 -
Tax Rate 15.33% - - - - - - -
Total Cost 4,302,000 8,327,000 3,730,000 4,288,000 4,359,000 4,578,000 5,026,000 -9.80%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 3.37 -109.33 3.62 1.58 2.44 -7.36 -15.89 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS 0.14 -3.97 0.13 0.06 0.10 -0.29 -0.63 -
EPS Diluted 0.14 -3.97 0.13 0.06 0.10 -0.29 -0.63 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.